Enlicitide, an oral cholesterol-lowering drug, is drawing interest from clinicians as an option for patients who want an injection-free treatment. Merck has also achieved a key step in its cholesterol drug pipeline, while a cholesterol medicine backed by McMaster University science has been approved for use in Canada.

Health outlets this week covered how exercise changes LDL cholesterol readings, and TODAY.com urged readers to be careful about following cholesterol advice found on social media. LDL cholesterol is often called the 'bad' type because elevated levels are associated with heart disease.